Cofoe Medical announced that on July 22, the company completed its first buyback of 496,200 A-shares through a dedicated repurchase securities account via centralized bidding, representing 0.24% of total share capital. The highest transaction price was RMB 53.87 per share, the lowest was RMB 50.60 per share, and the total transaction amount was RMB 26.1054 million. The company previously held a board meeting on June 26, 2026, and an extraordinary general meeting on July 20, approving a share buyback plan. It intends to use its own funds and a special stock buyback loan to repurchase some A-shares via centralized bidding, with a buyback amount of no less than RMB 100 million and no more than RMB 200 million, and a maximum buyback price of RMB 69.66 per share. Based on this calculation, the number of shares to be repurchased ranges from 1.4355 million to 2.8711 million, accounting for 0.61% to 1.22% of total share capital. The buyback period is within 12 months from the date of approval by the general meeting, and all repurchased shares will be cancelled to reduce registered capital.
Cofoe Medical Technology Co.Ltd.Company completed first buyback and plans to cancel shares, signaling capital return to shareholders.